Endometriosis

April 25, 2022

An expert reproductive endocrinologist explores the future treatment landscape for patients with endometriosis.

April 25, 2022

Hugh Taylor, MD, provides insight on remaining gaps in care in the endometriosis treatment landscape.

April 25, 2022

Dr Hugh Taylor discusses his treatment approach for patients with presumed endometriosis.

April 25, 2022

An expert in reproductive endocrinology reviews endometriosis treatment options for various patient populations, including patients with infertility, endometriomas, deep endometriosis, and effects on nonreproductive organs.

April 25, 2022

Dr Robert N. Taylor provides insight on emerging treatments and integrative therapies on the horizon with elagolix as well as real-world challenges using elagolix for endometriosis management.

April 25, 2022

Robert N. Taylor, MD, PhD, discusses key findings from clinical trial data on the dosing, pain relief profile, and adverse events of elagolix for patients with endometriosis.

April 25, 2022

An expert reproductive endocrinologist comments on the patient selection of aromatase inhibitors and the role of selective estrogen receptor modulators (SERMs) for endometriosis treatment.

April 25, 2022

Dr Robert N. Taylor examines the use of GnRH receptor antagonists, including elagolix, for the management of endometriosis.

April 25, 2022

Robert N. Taylor, MD, PhD, reviews first- and second-line therapies for the treatment of endometriosis.

April 25, 2022

An expert in reproductive endocrinology comments on the impact of endometriosis on a patient’s quality of life.